The government’s demonetisation move is likely to benefit companies due to shift from the unorganised to organised sector, believes Nikhil Khandelwal, MD of Systematix Shares & Stocks. Speaking from the company’s “Emerging Ideas’ conference, Khandelwal said that growth opportunities exist in the niche pharmaceutical space especially with focus on injectibles and oncology. He also sees growth opportunities in the veterinary pharmaceutical space. Watch video for more..
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
